| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |